Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015

    Access Status
    Fulltext not available
    Authors
    Alamneh, E.
    Stafford, Leanne
    Bereznicki, L.
    Date
    2017
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Alamneh, E. and Stafford, L. and Bereznicki, L. 2017. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015. Cardiovascular Therapeutics. 35 (3).
    Source Title
    Cardiovascular Therapeutics
    DOI
    10.1111/1755-5922.12254
    ISSN
    1755-5914
    School
    School of Pharmacy
    URI
    http://hdl.handle.net/20.500.11937/58417
    Collection
    • Curtin Research Publications
    Abstract

    © 2017 John Wiley & Sons Ltd Introduction: Contemporary Australian data regarding antithrombotic prescribing patterns following approval of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) are limited. Aim: The aim of this study was to assess antithrombotic prescribing patterns before, during, and after the clinical introduction of DOACs. Methods: Using digital medical records, this retrospective cohort study included all patients with AF as a primary or secondary diagnosis who were admitted to the Royal Hobart Hospital, Tasmania, Australia, between January 2011 and July 2015. Results: Antithrombotic agents were prescribed for 2078 (91.9%) of 2261 patients without documented contraindication to therapy. Higher rates of OAC prescribing were observed following government subsidization of DOACs in Quarter 3 (Q3) 2013 than anticoagulation rates in the prior quarters (54.4% in Q3, 2013, to 68.1% in Q2, 2015, P < .001), with the prescribing of warfarin and antiplatelet agents declining. DOACs, as a class, accounted for 18.4% of patients on antithrombotic therapy in 2011-2015; the proportion of patients receiving a DOAC steadily increased from 3.9% among OAC users in Q3, 2011, to 67.6% in Q2, 2015 (P < .001). In a subset of patients with newly diagnosed AF, patients commenced on DOACs were younger (70.4 vs 73.8 years, P=.04) and had lower stroke and bleeding risk scores (CHA2DS2-VASc 2.8 vs 3.3, P=.03, HAS-BLED 2 vs 3, P=.04) than patients who were newly prescribed warfarin. Conclusions: Direct oral anticoagulants rapidly became the most commonly prescribed class of antithrombotic medications in patients with AF soon after they became widely available. Warfarin and antiplatelet prescribing declined significantly, although a substantial proportion of patients continued to be prescribed antiplatelet therapy. Patients who were initiated on DOACs were typically younger with fewer comorbid conditions compared with those initiated on warfarin therapy.

    Related items

    Showing items related by title, author, creator and subject.

    • Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
      Admassie, E.; Chalmers, Leanne; Bereznicki, L. (2018)
      © 2018, The Author(s) 2018. Background: Although utilization of anticoagulation in patients with atrial fibrillation (AF) has increased in recent years, contemporary data regarding thromboembolism and mortality incidence ...
    • Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
      Admassie, E.; Stafford, Leanne; Bereznicki, L. (2017)
      © 2017 Elsevier Inc. Suboptimal guideline adherence and underuse of anticoagulants in patients with atrial fibrillation (AF) have been reported worldwide. This study aimed to compare anticoagulation practice in Australia ...
    • Antithrombotic regimens in patients with percutaneous coronary intervention whom an anticoagulant is indicated: A systematic review and network meta -analysis
      Bunmark, W.; Jinatongthai, P.; Vathesatogkit, P.; Thakkinstian, A.; Reid, Christopher; Wongcharoen, W.; Chaiyakunapruk, N.; Nathisuwan, S. (2018)
      Background: Patients undergoing percutaneous coronary intervention (PCI) who require anticoagulant therapy are at increased risk of bleeding. The optimal regimen for these patients is uncertain. This study aimed to compare ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.